newsfilter
← Latest News
GlobeNewswire·

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

  • Geron Corporation (NASDAQ: GERN) will host a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026, at 8:40 a.m. ET in Miami, FL.
  • A live & archived audio webcast of the event will be accessible via the Investors & Media section of Geron's website at www.geron.com.
  • Geron's first-in-class telomerase inhibitor RYTELO® (imetelstat) is approved in the US & EU for treating certain adult patients with lower-risk myelodysplastic syndromes with transfusion-dependent anemia.
  • The company is conducting a pivotal Phase 3 clinical trial of imetelstat for JAK-inhibitor relapsed/refractory myelofibrosis & other hematologic malignancy studies.
  • Dawn Schottlandt, Senior Vice President, Investor Relations & Corporate Affairs, is the designated contact for investors & media.